Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00840814 · ClinicalTrials.gov registry record
Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 55
- Enrollment target
NCT00840814 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 55 participants.
The verdict
NCT00840814 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
RATIONALE: Developing a symptom checklist for late-effect lymphedema may help doctors learn more about lymphedema in patients with head and neck cancer and plan the best treatment. PURPOSE: This phase I/II trial is developing a checklist of lymphedema symptoms in patients with head and neck cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00840814
The ClinicalTrials.gov registry entry for NCT00840814 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00840814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00840814 about?
NCT00840814 is a clinical study titled "Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer". RATIONALE: Developing a symptom checklist for late-effect lymphedema may help doctors learn more about lymphedema in patients with head and neck cancer and plan the best treatment. PURPOSE: This phase I/II trial is developing a checklist of lymphedema symptoms in patients with head and neck cancer.
What is the current status of trial NCT00840814?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2008-05. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT00840814?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.